Lincoln Pharmaceuticals Ltd.

View in App
679.00 +6.60 ▲1.0%

01 December 2023, 04:01:00 PM
Volume: 5,898

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lincolnpharma.com
Market Cap 1,359.22 Cr.
Enterprise Value(EV) 1,321.65 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 40.36 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 16.81 Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 272.59 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.49 Calculated using Price: 678.60
Dividend Yield 0.22 Period Ending 2023-03
No. of Shares Subscribed 2.00 Cr. 20,029,728 Shares
FaceValue 10
About Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Lincoln Pharmaceuticals Ltd. Performance

View details >>
1 Day
+0.98%
1 Week
+5.73%
1 Month
+36.65%
3 Month
+28.64%
6 Month
+82.09%
1 Year
+100.56%
2 Year
+110.15%
5 Year
+184.34%
10 Year
+2055.56%

Lincoln Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.32 19.49 17.29 16.63 19.75 17.67 18.32 17.35 15.59
Return on Capital Employed (%) 15.91 21.18 18.51 19.05 22.50 22.30 24.90 24.29 21.82
Return on Assets (%) 5.77 8.87 9.40 10.09 12.80 12.33 13.48 13.31 12.24

Lincoln Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 111 141 192 224 269 313 366 433 502 546
Non Curr. Liab. 33 34 32 25 28 43 26 11 38 14
Curr. Liab. 114 100 99 113 100 80 95 111 96 103
Minority Int. 3 0 0 0 0 0
Equity & Liab. 262 275 324 363 399 437 487 555 637 663
Non Curr. Assets 81 128 134 136 159 174 160 182 245 224
Curr. Assets 181 147 190 227 239 263 328 373 391 439
Misc. Exp. not W/O
Total Assets 262 275 324 363 399 437 487 555 637 663

Lincoln Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 266 400 360 361 366 386 424 472 510 538
Other Income 7 7 3 5 6 11 6 10 22 27
Total Income 273 408 363 366 372 398 430 482 533 564
Total Expenditure -240 -360 -314 -308 -299 -321 -337 -377 -421 -443
PBIDT 33 48 50 58 73 77 93 105 112 122
Interest -8 -10 -7 -5 -4 -2 -2 -1 -2 -2
Depreciation -5 -5 -6 -6 -7 -7 -8 -8 -9 -10
Taxation -5 -9 -9 -12 -13 -16 -21 -27 -28 -29
Exceptional Items
PAT 15 24 28 35 49 51 62 69 73 81
Minority Interest 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 15 24 28 35 49 51 62 69 73 81
Adjusted EPS 9 15 14 17 24 26 31 35 36 40

Lincoln Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 25 45 25 27 53 75 69 76 39
Cash Fr. Inv. 1 7 -42 -25 -12 -18 -31 -64 -78 -37
Cash Fr. Finan. -11 -32 -3 0 -11 -36 -38 -6 -3 -5
Net Change -4 -1 0 0 3 -1 7 -1 -5 -2
Cash & Cash Eqvt 5 4 3 3 7 5 12 11 7 5

Lincoln Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 40.28 42.08 42.05 44.08 44.08 46.34 47.00 48.67 50.53
Public 59.72 57.92 57.95 55.92 55.92 53.66 53.00 51.33 49.47
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Lincoln Pharmaceuticals Ltd. Announcements

View details >>
Fri, 03 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper advertisement with respect to un-audited financial results for the quarter and half year ended on 30.09.2023.
Fri, 03 Nov 2023
Intimation Of Placing Of The Matter Before The Board Of Directors W.R.T Identification Of Non-Compliance Of Regulation 17(1) Of SEBI (LODR) Regulations 2015 (''Listing Regulations'') And Subsequent Action Taken By The Exchange In The Matter.
Intimation of Placing of the matter before the board of Directors w.r.t Identification of Non-Compliance of Regulation 17(1) of SEBI (Listing Obligations & Disclosure Requirement) Regulation 2015 (Listing Regulations) And subsequent action taken by the exchange in this matter.
Thu, 02 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting
Un-Audited Financial Results for the Quarter and half year ended 30.09.2023

Lincoln Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Lincoln Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Lincoln Pharmaceuticals Ltd. FAQ's

What is Lincoln Pharma share price?
Can I buy Lincoln Pharma shares now?
What is the Dividend Yield of Lincoln Pharma?
What is the Market Cap of Lincoln Pharma?
What are the key metrics to analyse Lincoln Pharma?
What is the 52 Week High and Low of Lincoln Pharma?
What is the trend of Lincoln Pharma share price?